Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Cardiawave SA

Cardiawave Announces Positive 12-Month Results from Its “Valvosoft® FIM Study” and "Valvosoft® Pivotal Study" for the Treatment of Severe Symptomatic Aortic Stenosis (sSAS)
From Cardiawave SA
Via Business Wire
Cardiawave Announces Positive Six-Month Data from Valvosoft Pivotal Study at Transcatheter Cardiovascular Therapeutics (TCT) Conference
From Cardiawave SA
Via Business Wire
Cardiawave appoints Olivier Pierron as its Chief Executive Officer
From Cardiawave SA
Via Business Wire
Cardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis
From Cardiawave SA
Via Business Wire
Cardiawave Granted 3 New Patents Extending Its Intellectual Property Protection for Its Technology in the United States
From Cardiawave SA
Via Business Wire
Cardiawave Confirms the Safety of VALVOSOFT® its Non-Invasive Ultrasound Treatment for Aortic Stenosis
From Cardiawave SA
Via Business Wire
Cardiawave Announces the Success of Its Clinical Trial to Treat Aortic Stenosis Using VALVOSOFT®, Its Disruptive, Non-Invasive, Ultrasound Treatment
From Cardiawave SA
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.